Navigation Links
Sihuan Pharmaceutical Announces 2011 Annual Results
Date:3/19/2012

76.5%

71.8%

-Net profit margin

36.8%

50.3%

-Earnings per share — Basic (RMB cents)

15.90

13.03

-Final dividend per share (RMB cents)

2.5

-

-Special dividend per share (RMB cents)

7.2

-

 

 

 

 For the year ended 31 December 2011, the Company's revenue grew by 116.2% to RMB2,242.1 million. Net profit attributable to the Company's equity owners grew by 57.8% to RMB824.0 million. Importantly, all of this was achieved during what was a relatively challenging year for the Chinese pharmaceutical industry from an operational perspective.

During the past year, Sihuan Pharmaceutical has managed to identify and leverage opportunities for further growth. Industry consolidation has allowed the Company to seek valuable M&A opportunities in order to drive diversification and growth. On the back of steady growth from the Company's existing products, such as Kelinao, Anjieli, Qu'Ao and Qingtong, the Company significantly increased the variety in its product offering and produced several more flagship products from its newly acquired products, such as Oudimei and Yuanzhijiu. Sales of its newly acquired products recorded significant growth, exceeding one-third of the Company's total sales, meaning it is far less reliant on too few products and is creating a very balanced revenue stream.

Sihuan Pharmaceutical has had a year of breakthroughs in terms of R&D, with Category I innovative drug Apapenum and exclusive, Category IV new drug Cinepazide Mesilate receiving clinical approval from the State Food and Drug Administration (SFDA). The Company now has 10 innovative patented drugs at various stages of development and has more than 5 cases pending approval for production licenses, including the Roxatidine injection, a first-to-market generic drug.

The Com
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sihuan Pharmaceutical Achieves Important R&D Breakthrough
2. Branded Prescription Pharmaceutical Sales Outlook to 2016
3. Pharmaceuticals: Global Industry Guide
4. Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
5. JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals
6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments
7. Pharmaceutical & Healthcare Annual Deals Analysis 2012
8. Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition
9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
10. Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare Conference
11. S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... and HOUSTON, TX , Feb. 27, ... (TSX-V: EPI) and Bloom Burton & Co. Ltd. ("Bloom ... contractual lock-up (the "Lock-Up") 2,353,130 common shares of the ... originally subject to the Lock-Up. Of the Common Shares ... trading immediately upon release from the Lock-Up while the ...
(Date:2/27/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is ... Conference on March 10 in Miami Beach ... vice president and chief financial officer, and Susie ... a 25-minute question and answer session regarding the company ... Following a 5-minute break, a question and answer session ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015   Synageva ... ), a biopharmaceutical company developing therapeutic products for ... Disorders™ (NORD™), the European Organisation for Rare Diseases™ ... the world in observing Rare Disease Day. ... year, patient organizations, industry, and other participants conduct ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... A new ad campaign launched today highlights the clear choice ... for their state,s Medicaid program: cut benefits for patients or ... federal government could save $33 billion over the next ... to be more like those in Medicare and commercial plans. ...
... Irvine Pharmaceutical Services is pleased to announce the exciting ... team as the new Manager of Minerals.  Dr. Al-Ammar ...  Dr.  Al-Ammar has over fourteen years of experience with ... both the United States and Europe.  Additionally, Dr. Al-Ammar ...
Cached Medicine Technology:The Medicaid Choice: Cut Benefits for Patients or Overpayments to Independent Drugstores 2Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing 2
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation recently announced ... They stated that in many cases, missing an important time ... Many a time, delays in making an injury claim can ... As a result, experts at Jiwa Law Corporation suggest that ... injury lawyer in order to know more about their rights. ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... MO (PRWEB) February 28, 2015 ... provider of outsourced sales, marketing and supply chain ... client, BIOTA Botanicals, is bringing its award winning ... worldwide, BIOTA Botanicals’ products are specifically created to ... care experts, BIOTA is committed to marrying science ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 ... discuss federal testosterone lawsuits that have been filed by ... for the second week in March, the Firm notes. ... Court’s website, parties involved in the federal litigation will ... address matters related to prescription therapy treatments designed to ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 On ... Phishing Kits Make It Easy For Scammers To Steal Your ... anyone can get their hands on a DIY phishing kit, ... But it also touched on another important point about how ... these kits are often implemented, “like compromising legitimate content management ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... experienced by long-term survivors reveals the following. Some after ... cancer and a shortened life will continue to threaten ... approximately one-third of long-term, older-adult cancer survivors - researchers ... reports. ,It may be that these ...
... doctors in Rajasthan, including those of SMS Medical College ... today after receiving the copy of the Supreme Court ... ,'Though they have returned to work, their protest would ... organizations and relay hunger strike would continue to protest ...
... who undergoing Liver transplant reportedly experience physical fatigue and ... In a new study on this fatigue experienced by ... be a major problem that does not seem to ... study was published in the June 2006 issue of ...
... Observing that error of judgement of doctors while treating ... service // , the National Consumer Commission today dismissed ... Rs 143.08 crore filed by a US-based doctor whose ... suffered a deadly skin allergy. ,The National Consumer ...
... that high doses of the common painkiller like ibuprofen, which ... attack if taken in high doses for a long time//. ... was no danger for occasional users, and its risks were ... on it to lead normal lives. They claimed to have ...
... The National Consumer Commission today dismissed the medical negligence ... by a US-based doctor //who had alleged that his ... hospital., ,The National Consumer Disputes Redressal Commission Bench ... and Member Rajya Lakshmi, in its judgment, absolved five ...
Cached Medicine News:Health News:After Cancer Treatment Worry Continues – Researchers Find 2Health News:After Cancer Treatment Worry Continues – Researchers Find 3Health News:Fatigue After Liver Transplantation Does Not Lessen With Time 2Health News:Fatigue After Liver Transplantation Does Not Lessen With Time 3Health News:High Doses Of Common Pain killers Can Double The Chances Of Heart attack 2
... 4420 Colloid Osmometer. Rapid measurement of ... prediction of edema onset in clinical ... sample and reference chambers to simulate ... membrane in the establishment of osmotic ...
... Automated Cortisol ... for increased laboratory workflow, Excellent ... Cortisol assay provides confidence,in assay ... Cortisol Serum Reference Panels delivers ...
Quantitative determination of cortisol levels in serum and urine. Cross-reactivity with dexamethasone: 0.2% (suppression test).Time to first result: 30 minutes....
... immunoassay system built around the many positive ... important addition of Logic Driven Incubation (LDI). ... for optimal performance with the fastest possible ... such as the cardiac biomarkers and HCG ...
Medicine Products: